Recombinant human anti-PD-1 monoclonal antibody(Eastern Biotech)

重组抗PD-1全人源单克隆抗体（东方百泰生物）

Report date: 2022/01/17 12:14:22

Base Information

Drug NameRecombinant human anti-PD-1 monoclonal antibody(Eastern Biotech)
Drug Alias NameJY034JY-034
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionAnti-PD-1
TargetsProgrammed cell death protein 1
Therapy Area/IndicationsSolid tumours
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusIND
Highest Status in ChinaIND
Originator CompaniesBeijing Eastern Biotech Co Ltd
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesBeijing Eastern Biotech Co Ltd
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A